Hypnosis and self-hypnosis, administered and taught by nurses, for the reduction of chronic pain: a controlled clinical trial
ISRCTN | ISRCTN32129167 |
---|---|
DOI | https://doi.org/10.1186/ISRCTN32129167 |
Secondary identifying numbers | N/A |
- Submission date
- 06/09/2005
- Registration date
- 04/10/2005
- Last edited
- 10/09/2009
- Recruitment status
- No longer recruiting
- Overall study status
- Completed
- Condition category
- Signs and Symptoms
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Record updated in last year
Plain English summary of protocol
Not provided at time of registration
Contact information
Dr Bernard Burnand
Scientific
Scientific
IUMSP
Bugnon 17
Lausanne
CH-1010
Switzerland
Study information
Study design | Randomised controlled trial |
---|---|
Primary study design | Interventional |
Secondary study design | Randomised controlled trial |
Study setting(s) | Not specified |
Study type | Treatment |
Scientific title | |
Study objectives | Hypnosis and auto-hypnosis do not reduce pain in patients with chronic pain |
Ethics approval(s) | Not provided at time of registration |
Health condition(s) or problem(s) studied | Various conditions engendering chronic pain |
Intervention | Hypnosis and auto-hypnosis administered and taught by trained nurses |
Intervention type | Other |
Primary outcome measure | Level of pain (VAS) |
Secondary outcome measures | 1. Physical activity (tridimensional accelerometer) 2. Health related quality of life (SF-36) |
Overall study start date | 01/05/1993 |
Completion date | 31/12/1994 |
Eligibility
Participant type(s) | Patient |
---|---|
Age group | Adult |
Lower age limit | 18 Years |
Sex | Both |
Target number of participants | 2 x 65 = 130 |
Key inclusion criteria | 1. To be referred (including occasional self-referral) for the management of chronic pain 2. To live within manageable distances from the hospital 3. To be aged 18 or above 4. To understand and speak French adequately 5. To be able to see, hear and communicate (i.e. no alteration of consciousness) 6. To have no diagnosis of mental illness (e.g. psychosis) 7. To give informed consent |
Key exclusion criteria | Patients were excluded from the study whenever they wished and/or when no conventional treatment could be proposed. |
Date of first enrolment | 01/05/1993 |
Date of final enrolment | 31/12/1994 |
Locations
Countries of recruitment
- Switzerland
Study participating centre
IUMSP
Lausanne
CH-1010
Switzerland
CH-1010
Switzerland
Sponsor information
Hospital of Morges (Switzerland)
Hospital/treatment centre
Hospital/treatment centre
Morges
CH-1110
Switzerland
https://ror.org/026qe1m81 |
Funders
Funder type
Government
Swiss National Science Foundation (Switzerland) (SNF 4034-35883)
Private sector organisation / Trusts, charities, foundations (both public and private)
Private sector organisation / Trusts, charities, foundations (both public and private)
- Alternative name(s)
- Schweizerischer Nationalfonds, Swiss National Science Foundation, Fonds National Suisse de la Recherche Scientifique, Fondo Nazionale Svizzero per la Ricerca Scientifica, Fonds National Suisse, Fondo Nazionale Svizzero, Schweizerische Nationalfonds, SNF, SNSF, FNS
- Location
- Switzerland
Results and Publications
Intention to publish date | |
---|---|
Individual participant data (IPD) Intention to share | No |
IPD sharing plan summary | Not provided at time of registration |
Publication and dissemination plan | Not provided at time of registration |
IPD sharing plan |
Study outputs
Output type | Details | Date created | Date added | Peer reviewed? | Patient-facing? |
---|---|---|---|---|---|
Protocol article | protocol | 01/08/1994 | Yes | No |